Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar by Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker, Kris L. L. Movig, Johan Kuijvenhoven, Toine C. G. Egberts, Thijs J. Giezen

Get full text

Does immediate smart feedback on therapy adherence and inhalation technique improve asthma control in children with uncontrolled asthma? A study protocol of the IMAGINE I study by Esther T. Sportel, Martijn J. Oude Wolcherink, Job van der Palen, Anke Lenferink, Boony J. Thio, Kris L. L. Movig, Marjolein G. J. Brusse-Keizer

Get full text

Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease. by Marieke G M Weernink, Janine A van Til, Jeroen P P van Vugt, Kris L L Movig, Catharina G M Groothuis-Oudshoorn, Maarten J IJzerman

Get full text

Switching TNFα inhibitors: Patterns and determinants by Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker, Mark C. H. de Groot, Kris L. L. Movig, Johan Kuijvenhoven, Toine C. G. Egberts, Hubert G. M. Leufkens, Thijs J. Giezen

Get full text

Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retro... by Willemien J Kruik-Kollöffel, Job van der Palen, Carine J M Doggen, Marissa C van Maaren, H Joost Kruik, Edith M Heintjes, Kris L L Movig, Gerard C M Linssen

Get full text